Cairns Base Hospital, Australia.
Malar J. 2011 Aug 3;10:217. doi: 10.1186/1475-2875-10-217.
Acute renal failure is a common complication of severe malaria in adults, and without renal replacement therapy (RRT), it carries a poor prognosis. Even when RRT is available, delaying its initiation may increase mortality. Earlier identification of patients who will need RRT may improve outcomes.
Prospectively collected data from two intervention studies in adults with severe malaria were analysed focusing on laboratory features on presentation and their association with a later requirement for RRT. In particular, laboratory indices of acute tubular necrosis (ATN) and acute kidney injury (AKI) that are used in other settings were examined.
Data from 163 patients were available for analysis. Whether or not the patients should have received RRT (a retrospective assessment determined by three independent reviewers) was used as the reference. Forty-three (26.4%) patients met criteria for dialysis, but only 19 (44.2%) were able to receive this intervention due to the limited availability of RRT. Patients with impaired renal function on admission (creatinine clearance < 60 ml/min) (n = 84) had their laboratory indices of ATN/AKI analysed. The plasma creatinine level had the greatest area under the ROC curve (AUC): 0.83 (95% confidence interval 0.74-0.92), significantly better than the AUCs for, urinary sodium level, the urea to creatinine ratio (UCR), the fractional excretion of urea (FeUN) and the urinary neutrophil gelatinase-associated lipocalcin (NGAL) level. The AUC for plasma creatinine was also greater than the AUC for blood urea nitrogen level, the fractional excretion of sodium (FeNa), the renal failure index (RFI), the urinary osmolality, the urine to plasma creatinine ratio (UPCR) and the creatinine clearance, although the difference for these variables did not reach statistical significance.
In adult patients with severe malaria and impaired renal function on admission, none of the evaluated laboratory indices was superior to the plasma creatinine level when used to predict a later requirement for renal replacement therapy.
急性肾衰竭是成人严重疟疾的常见并发症,如果没有肾脏替代疗法(RRT),其预后不良。即使有 RRT 可用,延迟开始也可能增加死亡率。更早地识别需要 RRT 的患者可能会改善预后。
对两项成人严重疟疾干预研究中前瞻性收集的数据进行分析,重点关注入院时的实验室特征及其与随后需要 RRT 的相关性。特别检查了在其他情况下用于急性肾小管坏死(ATN)和急性肾损伤(AKI)的实验室指标。
共有 163 名患者的数据可用于分析。是否应接受 RRT(由三位独立审查员进行的回顾性评估)作为参考。43 名(26.4%)患者符合透析标准,但由于 RRT 可用性有限,只有 19 名(44.2%)患者能够接受该干预措施。入院时肾功能受损(肌酐清除率 <60 ml/min)的患者(n=84)分析了其 ATN/AKI 的实验室指标。血浆肌酐水平的 ROC 曲线下面积(AUC)最大:0.83(95%置信区间 0.74-0.92),明显优于尿钠水平、尿素与肌酐比值(UCR)、尿尿素排泄分数(FeUN)和尿中性粒细胞明胶酶相关脂质运载蛋白(NGAL)水平的 AUC。血浆肌酐的 AUC 也大于血尿素氮水平、尿钠排泄分数(FeNa)、肾衰竭指数(RFI)、尿渗透压、尿/血浆肌酐比值(UPCR)和肌酐清除率的 AUC,尽管这些变量的 AUC 差异没有达到统计学意义。
在入院时肾功能受损的成人严重疟疾患者中,当用于预测随后需要肾脏替代治疗时,评估的实验室指标均不如血浆肌酐水平。